Literature DB >> 15583729

Plasma fibrinogen concentration predicts the risk of myocardial infarction differently in various parts of Europe: effects of beta-fibrinogen genotype and environmental factors. The HIFMECH Study.

Maria Nastase Mannila1, Angela Silveira, Emma Hawe, Per Eriksson, Marie Françoise Aillaud, Irene Juhan-Vague, John Yudkin, Maurizio Margaglione, Giovanni di Minno, Luciana Mussoni, Elena Tremoli, Steve Humphries, Anders Hamsten.   

Abstract

The propensity to atherothrombotic disease differs in Europe, with high-risk regions located in the North of Europe and lowrisk regions in the South of Europe. The HIFMECH study (Hypercoagulability and Impaired Fibrinolytic function MECHanisms predisposing to myocardial infarction (MI) study) was undertaken to elucidate genetic and environmental mechanisms underlying MI based on investigations of postinfarction patients and healthy individuals recruited from Stockholm, Sweden, London, England (North of Europe), Marseille, France and San Giovanni Rotondo, Italy (South of Europe). In the present report, emphasis was placed on fibrinogen, a multifunctional protein, widely recognized as an independent predictor of atherothrombotic disease. The adjusted plasma fibrinogen concentration was an independent discriminator between cases and controls in London (SOR 3.58; 95% CI 1.31; 9.83), but not in the other centres. Genotyping for six beta-fibrinogen promoter single nucleotide polymorphisms was performed of which -249C/T, -455G/A and -854G/A were used in analysis as a consequence of the linkage disequilibrium pattern. Four haplotypes, with similar distribution across Europe, were detected: CGG (46.7%), CAG (20.3%), TGG (18.2%) and CGA (14.8%). A significant haplotype effect on plasma fibrinogen concentration was observed in patients (p < 0.001) but not in controls (p = 0.08). The -455G/A genotype related to plasma fibrinogen concentration amongst patients along with centre and IL-6 concentration (together explaining 11.5% of the variation), whereas predictors amongst controls included centre, body mass index, IL-6 and smoking habit (explaining 15.7%). Thus, plasma fibrinogen concentration contributes differently to MI across Europe, and a disease-related stimulus is required to evoke allele-specific regulation of fibrinogen synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583729     DOI: 10.1160/TH04-06-0339

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  3 in total

1.  Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphisms.

Authors:  Petter Ljungman; Tom Bellander; Alexandra Schneider; Susanne Breitner; Francesco Forastiere; Regina Hampel; Thomas Illig; Bénédicte Jacquemin; Klea Katsouyanni; Stephanie von Klot; Wolfgang Koenig; Timo Lanki; Fredrik Nyberg; Juha Pekkanen; Riccardo Pistelli; Christos Pitsavos; Mårten Rosenqvist; Jordi Sunyer; Annette Peters
Journal:  Environ Health Perspect       Date:  2009-04-06       Impact factor: 9.031

2.  Linkage study of fibrinogen levels: the Strong Heart Family Study.

Authors:  Lyle G Best; Kari E North; Xia Li; Vittorio Palmieri; Jason G Umans; Jean MacCluer; Sandy Laston; Karin Haack; Harald Goring; Vincent P Diego; Laura Almasy; Elisa T Lee; Russell P Tracy; Shelley Cole
Journal:  BMC Med Genet       Date:  2008-08-12       Impact factor: 2.103

3.  Βeta-fibrinogen gene promoter A -455 allele associated with poor longterm survival among 55-71 years old Caucasian women in Finnish stroke cohort.

Authors:  Mika Martiskainen; Niku Oksala; Tarja Pohjasvaara; Markku Kaste; Anni Oksala; Pekka J Karhunen; Timo Erkinjuntti
Journal:  BMC Neurol       Date:  2014-06-22       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.